2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings

Author:

Revell Andrew D1,Wang Dechao1,Perez-Elias Maria-Jesus2ORCID,Wood Robin3,Cogill Dolphina3,Tempelman Hugo4,Hamers Raph L5ORCID,Reiss Peter56,van Sighem Ard6,Rehm Catherine A7,Agan Brian8,Alvarez-Uria Gerardo9,Montaner Julio S G10,Lane H Clifford7,Larder Brendan A1,Reiss Peter,van Sighem Ard,Montaner Julio,Harrigan Richard,de Wit Tobias Rinke,Hamers Raph,Sigaloff Kim,Agan Brian,Marconi Vincent,Wegner Scott,Sugiura Wataru,Zazzi Maurizio,Kaiser Rolf,Schuelter Eugen,Streinu-Cercel Adrian,Alvarez-Uria Gerardo,Garcia Federico,de Oliveira Tulio,Gatell Jose,Lazzari Elisa,Gazzard Brian,Nelson Mark,Pozniak Anton,Mandalia Sundhiya,Smith Colette,Ruiz Lidia,Clotet Bonaventura,Staszewski Schlomo,Torti Carlo,Lane Cliff,Metcalf Julie,Rehm Catherine A,Perez-Elias Maria-Jesus,Vella Stefano,Dettorre Gabrielle,Carr Andrew,Norris Richard,Hesse Karl,Vlahakis Emanuel,Tempelman Hugo,Barth Roos,Wood Robin,Morrow Carl,Cogill Dolphina,Hoffmann Chris,Ene Luminita,Dragovic Gordana,Diaz Ricardo,Sucupira Cecilia,Sued Omar,Cesar Carina,Madero Juan Sierra,Balakrishnan Pachamuthu,Saravanan Shanmugam,Emery Sean,Cooper David,Torti Carlo,Baxter John,Monno Laura,Torti Carlo,Gatell Jose,Clotet Bonventura,Picchio Gaston,deBethune Marie-Pierre,Perez-Elias Maria-Jesus,Emery Sean,Khabo Paul,Ledwaba Lotty,

Affiliation:

1. The HIV Resistance Response Database Initiative (RDI), London, UK

2. Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain

3. Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

4. Ndlovu Care Group, Elandsdoorn, South Africa

5. Departments of Internal Medicine and Global Health, Academic Medical Centre of the University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands

6. Stichting HIV Monitoring, Amsterdam, The Netherlands

7. National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA

8. Uniformed Services University of the Health Sciences and Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA

9. Rural Development Trust (RDT) Hospital, Bathalapalli, India

10. BC Centre for Excellence in HIV/AIDS, Vancouver, Canada

Abstract

Abstract Objectives With the goal of facilitating the use of HIV-TRePS to optimize therapy in settings with limited healthcare resources, we aimed to develop computational models to predict treatment responses accurately in the absence of commonly used baseline data. Methods Twelve sets of random forest models were trained using very large, global datasets to predict either the probability of virological response (classifier models) or the absolute change in viral load in response to a new regimen (absolute models) following virological failure. Two ‘standard’ models were developed with all baseline variables present and 10 others developed without HIV genotype, time on therapy, CD4 count or any combination of the above. Results The standard classifier models achieved an AUC of 0.89 in cross-validation and independent testing. Models with missing variables achieved AUC values of 0.78–0.90. The standard absolute models made predictions that correlated significantly with observed changes in viral load with a mean absolute error of 0.65 log10 copies HIV RNA/mL in cross-validation and 0.69 log10 copies HIV RNA/mL in independent testing. Models with missing variables achieved values of 0.65–0.75 log10 copies HIV RNA/mL. All models identified alternative regimens that were predicted to be effective for the vast majority of cases where the new regimen prescribed in the clinic failed. All models were significantly better predictors of treatment response than genotyping with rules-based interpretation. Conclusions These latest models that predict treatment responses accurately, even when a number of baseline variables are not available, are a major advance with greatly enhanced potential benefit, particularly in resource-limited settings. The only obstacle to realizing this potential is the willingness of healthcare professions to use the system.

Funder

National Cancer Institute

National Institutes of Health

Department of Health and Human Services

U.S. Government

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Reference22 articles.

1. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention” experience in a Canadian setting;Montaner;PLoS One,2014

2. Antiretroviral drugs for the treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel;Saag;JAMA,2018

3. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight);Williams;HIV Med,2014

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3